Skip to content
The Policy VaultThe Policy Vault

DaraprimCareFirst (Caremark)

Cystoisosporiasis (treatment)

Initial criteria

  • The requested drug is being prescribed for the treatment of cystoisosporiasis AND the patient has experienced an intolerance or has a contraindication to sulfamethoxazole/trimethoprim.

Approval duration

6 months